메뉴 건너뛰기




Volumn 15, Issue 9, 2005, Pages 1089-1094

Novel thyrotropin receptor germline mutation (Ile568Val) in a Saxonian family with hereditary nonautoimmune hyperthyroidism

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; CYCLIC AMP; GENOMIC DNA; INOSITOL PHOSPHATE; ISOLEUCINE; LEUCINE; LEVOTHYROXINE; LIOTHYRONINE; PHENYLALANINE; THIAMAZOLE; THYROID PEROXIDASE ANTIBODY; THYROID STIMULATING IMMUNOGLOBULIN; THYROTROPIN; THYROTROPIN RECEPTOR; THYROTROPIN RECEPTOR ANTIBODY; THYROXINE; VALINE;

EID: 26944450868     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2005.15.1089     Document Type: Article
Times cited : (34)

References (20)
  • 2
    • 0034925736 scopus 로고    scopus 로고
    • Clinical review 133: Progress in understanding the etiology of thyroid autonomy
    • Krohn K, Paschke R 2001 Clinical review 133: Progress in understanding the etiology of thyroid autonomy. J Clin Endocrinol Metab 86:3336-3345.
    • (2001) J Clin Endocrinol Metab , vol.86 , pp. 3336-3345
    • Krohn, K.1    Paschke, R.2
  • 4
    • 0026743033 scopus 로고
    • The thyrotropin receptor and the regulation of thyrocyte function and growth
    • Vassart G, Dumont JE 1992 The thyrotropin receptor and the regulation of thyrocyte function and growth. Endocr Rev 13:596-611.
    • (1992) Endocr Rev , vol.13 , pp. 596-611
    • Vassart, G.1    Dumont, J.E.2
  • 5
    • 0034505679 scopus 로고    scopus 로고
    • Novel TSHR germline mutation (Met463Val) masquerading as Graves' disease in a large Welsh kindred with hyperthyroidism
    • Fuhrer D, Warner J, Sequeira M, Paschke R, Gregory J, Ludgate M 2000 Novel TSHR germline mutation (Met463Val) masquerading as Graves' disease in a large Welsh kindred with hyperthyroidism. Thyroid 10:1035-1041.
    • (2000) Thyroid , vol.10 , pp. 1035-1041
    • Fuhrer, D.1    Warner, J.2    Sequeira, M.3    Paschke, R.4    Gregory, J.5    Ludgate, M.6
  • 6
    • 0347363461 scopus 로고    scopus 로고
    • The thyrotropin receptor mutation database: Update 2003
    • Fuhrer D, Lachmund P, Nebel IT, Paschke R 2003 The thyrotropin receptor mutation database: update 2003. Thyroid 13:1123-1126.
    • (2003) Thyroid , vol.13 , pp. 1123-1126
    • Fuhrer, D.1    Lachmund, P.2    Nebel, I.T.3    Paschke, R.4
  • 7
    • 1842295776 scopus 로고    scopus 로고
    • Clinical consequences of activating germline mutations of TSH receptor, the concept of toxic hyperplasia
    • Leclere J, Bene MC, Aubert V, Klein M, Pascal-Vigneron V, Weryha G, Faure G 1997 Clinical consequences of activating germline mutations of TSH receptor, the concept of toxic hyperplasia. Horm Res 47:158-162.
    • (1997) Horm Res , vol.47 , pp. 158-162
    • Leclere, J.1    Bene, M.C.2    Aubert, V.3    Klein, M.4    Pascal-Vigneron, V.5    Weryha, G.6    Faure, G.7
  • 8
    • 0034463802 scopus 로고    scopus 로고
    • Detection of thyroid-stimulating hormone receptor and Gsalpha mutations in 75 toxic thyroid nodules by denaturing gradient gel electrophoresis
    • Trulzsch B, Krohn K, Wonerow P, Chey S, Holzapfel HP, Ackermann F, Fuhrer D, Paschke R 2001 Detection of thyroid-stimulating hormone receptor and Gsalpha mutations in 75 toxic thyroid nodules by denaturing gradient gel electrophoresis. J Mol Med 78:684-691.
    • (2001) J Mol Med , vol.78 , pp. 684-691
    • Trulzsch, B.1    Krohn, K.2    Wonerow, P.3    Chey, S.4    Holzapfel, H.P.5    Ackermann, F.6    Fuhrer, D.7    Paschke, R.8
  • 9
    • 0030734932 scopus 로고    scopus 로고
    • Identification of a new thyrotropin receptor germline mutation (Leu629Phe) in a family with neonatal onset of autosomal dominant nonautoimmune hyperthyroidism
    • Fuhrer D, Wonerow P, Willgerodt H, Paschke R 1997 Identification of a new thyrotropin receptor germline mutation (Leu629Phe) in a family with neonatal onset of autosomal dominant nonautoimmune hyperthyroidism. J Clin Endocrinol Metab 82:4234-4238.
    • (1997) J Clin Endocrinol Metab , vol.82 , pp. 4234-4238
    • Fuhrer, D.1    Wonerow, P.2    Willgerodt, H.3    Paschke, R.4
  • 10
    • 85016731055 scopus 로고
    • Using PCR to engineer DNA
    • Erlich HA (ed) Stockton Press, New York
    • Higuchi R 1989 Using PCR to engineer DNA. In: Erlich HA (ed) PCR Technology. Stockton Press, New York, pp. 61-70.
    • (1989) PCR Technology , pp. 61-70
    • Higuchi, R.1
  • 12
    • 0020636518 scopus 로고
    • Rapid accumulation of inositol trisphosphate reveals that agonists hydrolyse polyphosphoinositides instead of phosphatidylinositol
    • Berridge MJ 1983 Rapid accumulation of inositol trisphosphate reveals that agonists hydrolyse polyphosphoinositides instead of phosphatidylinositol. Biochem J 212:849-858.
    • (1983) Biochem J , vol.212 , pp. 849-858
    • Berridge, M.J.1
  • 13
    • 0033790195 scopus 로고    scopus 로고
    • Functional characterization of five constitutively activating thyrotrophin receptor mutations
    • Wonerow P, Chey S, Fuhrer D, Holzapfel HP, Paschke R 2000 Functional characterization of five constitutively activating thyrotrophin receptor mutations. Clin Endocrinol (Oxf) 53:461-468.
    • (2000) Clin Endocrinol (Oxf) , vol.53 , pp. 461-468
    • Wonerow, P.1    Chey, S.2    Fuhrer, D.3    Holzapfel, H.P.4    Paschke, R.5
  • 14
    • 0029044073 scopus 로고
    • Somatic mutations causing constitutive activity of the thyrotropin receptor are the major cause of hyperfunctioning thyroid adenomas: Identification of additional mutations activating both the cyclic adenosine 3′,5′-monophosphate and inositol phosphate-Ca2+ cascades
    • Parma J, Van Sande J, Swillens S, Tonacchera M, Dumont J, Vassart G 1995 Somatic mutations causing constitutive activity of the thyrotropin receptor are the major cause of hyperfunctioning thyroid adenomas: Identification of additional mutations activating both the cyclic adenosine 3′,5′- monophosphate and inositol phosphate-Ca2+ cascades. Mol Endocrinol 9:725-733.
    • (1995) Mol Endocrinol , vol.9 , pp. 725-733
    • Parma, J.1    Van Sande, J.2    Swillens, S.3    Tonacchera, M.4    Dumont, J.5    Vassart, G.6
  • 16
    • 0034853605 scopus 로고    scopus 로고
    • The first activating TSH receptor mutation in transmembrane domain 1 identified in a family with nonautoimmune hyperthyroidism
    • Biebermann H, Schoneberg T, Hess C, Germak J, Gudermann T, Gruters A 2001 The first activating TSH receptor mutation in transmembrane domain 1 identified in a family with nonautoimmune hyperthyroidism. J Clin Endocrinol Metab 86:4429-4433.
    • (2001) J Clin Endocrinol Metab , vol.86 , pp. 4429-4433
    • Biebermann, H.1    Schoneberg, T.2    Hess, C.3    Germak, J.4    Gudermann, T.5    Gruters, A.6
  • 18
    • 0034895145 scopus 로고    scopus 로고
    • A free carboxylate oxygen in the side chain of position 674 in transmembrane domain 7 is necessary for TSH receptor activation
    • Neumann S, Krause G, Chey S, Paschke R 2001 A free carboxylate oxygen in the side chain of position 674 in transmembrane domain 7 is necessary for TSH receptor activation. Mol Endocrinol 15:1294-1305.
    • (2001) Mol Endocrinol , vol.15 , pp. 1294-1305
    • Neumann, S.1    Krause, G.2    Chey, S.3    Paschke, R.4
  • 19
    • 0034987731 scopus 로고    scopus 로고
    • Effects of mutations involving the highly conserved S281HCC motif in the extracellular domain of the thyrotropin (TSH) receptor on TSH binding and constitutive activity
    • Ho SC, Van Sande J, Lefort A, Vassart G, Costagliola S 2001 Effects of mutations involving the highly conserved S281HCC motif in the extracellular domain of the thyrotropin (TSH) receptor on TSH binding and constitutive activity. Endocrinology 142:2760-2767.
    • (2001) Endocrinology , vol.142 , pp. 2760-2767
    • Ho, S.C.1    Van Sande, J.2    Lefort, A.3    Vassart, G.4    Costagliola, S.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.